Transaction Breakdown
Companies & Roles
Discretionary Trading P&L
Holdings
Transaction History
About Brennan Daniel J.
Brennan Daniel J. (SEC CIK 0001595612) files insider reports with the SEC as Director of VERTEX PHARMACEUTICALS INC / MA (VRTX), Director of MADRIGAL PHARMACEUTICALS, INC. (MDGL) and Director of WATERS CORP /DE/ (WAT). Signal8 also holds filings tied to 1 other company.
Signal8 holds 13 ownership filings by Brennan Daniel J. (2 Form 3, 11 Form 4), filed between Jan 3, 2025 and Oct 22, 2026. Those filings report 30 transactions, the latest on Oct 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Brennan Daniel J.'s filings is in BOSTON, MA.
Other insiders filing for VERTEX PHARMACEUTICALS INC / MA (VRTX)
- SACHS BRUCE I, Director
- Garber Alan M, Director
- van Grunsven Jasper, EVP, CP and NPPO
- Ambrose Kristen, SVP & Chief Accounting Officer
- Tatsis Ourania, EVP, Chief Reg. & Quality Off.
- Sachdev Amit, EVP Chief Patient & Ext Af Off